EMAIL DETAILS

.footer .iOSLink a { color: #666666 !important; text-decoration: none !important; } @media only screen and (max-device-width: 480px) { body { padding: 10px !important; } .one-column p, .one-column li { font-size: 19px !important; line-height: 29px !important; } }A daily digest of opinions and analysisNot Built to LastWatch the fund-flow data, says Eric Balchunas, and you'll have second thoughts about that post-election run in the stock market.Follow the MoneyThe life and death of great American shopping malls: Conor Sen maps the areas losing their retail giants. The stakes are not just Auntie Anne's pretzels.Mob RuleA populist approach to government isn't always bad. But, warns Tyler Cowen, it's always a bad way to run the most complex parts of government, like the Fed.Drug-Cost Proposal Is DOAThe effect of letting Medicare negotiate on drug prices would be roughly ... $0. Megan McArdle explains, in case anyone was tempted by President-elect Donald Trump's call for cost cutting.Ritholtz’s ReadsDavos Wonders If It’s Part of the Problem (Bloomberg)Great to See You, Active Management -- Are You Still Alive? (Wealth of Common Sense)What the Fed’s Move May Mean (Fidelity)(Read Barry Ritholtz’s full news roundup.)Bloomberg GadflyThe true meaning of Christmas (for retailers)Bonds' bull market is ending ... sometimeA nosedive for the drone industry(Read more from BV’s sister site for fast business commentary.)Bloomberg L.P. ● 731 Lexington Avenue, New York, NY 10022Web ● Facebook ● TwitterFeedback ● Unsubscribe

If you believe this has been sent to you in error, please click <http://link.mail.bloombergbusiness.com/oc/57d81a102ddf9c08613460d754hrp.mj4/8104470d> to safely unsubscrib